Ventricular tachycardia in two patients with AIDS receiving ganciclovir (DHPG)
- 1 August 1990
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 4 (8) , 807-810
- https://doi.org/10.1097/00002030-199008000-00014
Abstract
We report two cases of patients who developed ventricular tachycardia while receiving intravenous infusions of ganciclovir [9-(1,3-dihydroxy-2-propoxy)methylguanine, DHPG]. Worsening cytomegalovirus infection prompted renewal of ganciclovir therapy under close cardiac monitoring in one of these patients, and ventricular tachycardia recurred. The close temporal relationship between administration of the drug and onset of the arrhythmias in conjunction with the absence of other factors known to predispose to arrhythmias suggest that ganciclovir may have played a role in the development of arrhythmias in these patients. The clinical courses of the patients are discussed, as are autopsy results.This publication has 3 references indexed in Scilit:
- Serious Cytomegalovirus Disease in the Acquired Immunodeficiency Syndrome (AIDS)Annals of Internal Medicine, 1988
- Prevalent myocarditis at necropsy in the acquired immunodeficiency syndromeJournal of the American College of Cardiology, 1988
- Cardiac lesions in acquired immune deficiency syndrome (AIDS)Journal of the American College of Cardiology, 1985